Flørenes et al. [28] have shown that expression of cyclin D3 is an important factor in predicting the clinical outcome for patients with superficial spreading melanoma, whereas the level of cyclin D1 expression has no impact on tumor progression. Here, CCND1 is linked to neoplasm.